1A7C | A:171-280,A:326-349 | HUMAN PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH A PENTAPEPTIDE |
1ANT | L:225-320,L:378-430; I:225-320,I:383-432 | BIOLOGICAL IMPLICATIONS OF A 3 ANGSTROMS STRUCTURE OF DIMERIC ANTITHROMBIN |
1AS4 | A:194-288,A:348-358 | CLEAVED ANTICHYMOTRYPSIN A349R |
1ATH | B:225-320,B:383-427; A:225-320,A:383-430 | THE INTACT AND CLEAVED HUMAN ANTITHROMBIN III COMPLEX AS A MODEL FOR SERPIN-PROTEINASE INTERACTIONS |
1ATU | A:195-289 | UNCLEAVED ALPHA-1-ANTITRYPSIN |
1AZX | I:225-320,I:383-430; L:225-320,L:383-430 | ANTITHROMBIN/PENTASACCHARIDE COMPLEX |
1B3K | A:171-280,A:326-335; B:171-280,B:326-350; C:171-280,C:326-335; D:171-280,D:326-350 | PLASMINOGEN ACTIVATOR INHIBITOR-1 |
1BR8 | L:225-320,L:383-429; I:225-320,I:384-429 | IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBIN |
1BY7 | A:208-309,A:385-411 | HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2. LOOP (66-98) DELETION MUTANT |
1C5G | A:194-303,A:349-358 | PLASMINOGEN ACTIVATOR INHIBITOR-1 |
1D5S | A:195-289 | CRYSTAL STRUCTURE OF CLEAVED ANTITRYPSIN POLYMER |
1DB2 | A:171-280,A:326-335; B:171-280,B:326-350 | CRYSTAL STRUCTURE OF NATIVE PLASMINOGEN ACTIVATOR INHIBITOR-1 |
1DVM | A:171-280,A:326-335; B:171-280,B:326-335; C:171-280,C:326-346; D:171-280,D:326-339 | ACTIVE FORM OF HUMAN PAI-1 |
1DVN | A:171-280,A:326-335 | LATENT FORM OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) |
1DZG | L:225-320,L:383-429; I:225-320,I:383-430 | N135Q-S380C-ANTITHROMBIN-III |
1DZH | I:225-320,I:383-429; L:225-320,L:383-429 | P14-FLUORESCEIN-N135Q-S380C-ANTITHROMBIN-III |
1E03 | I:225-320,I:383-430; L:225-320,L:383-430 | PLASMA ALPHA ANTITHROMBIN-III AND PENTASACCHARIDE |
1E04 | L:225-320,L:383-429; I:225-320,I:383-430 | PLASMA BETA ANTITHROMBIN-III |
1E05 | I:225-320,I:383-430; L:225-320,L:383-430 | PLASMA ALPHA ANTITHROMBIN-III |
1EZX | A:195-289 | CRYSTAL STRUCTURE OF A SERPIN:PROTEASE COMPLEX |
1HP7 | A:195-289 | A 2.1 ANGSTROM STRUCTURE OF AN UNCLEAVED ALPHA-1-ANTITRYPSIN SHOWS VARIABILITY OF THE REACTIVE CENTER AND OTHER LOOPS |
1IMV | A:16-28,A:193-299,A:342-398 | 2.85 A CRYSTAL STRUCTURE OF PEDF |
1IZ2 | A:195-289,A:359-394 | INTERACTIONS CAUSING THE KINETIC TRAP IN SERPIN PROTEIN FOLDING |
1JMJ | A:279-377,A:427-477; B:279-377,B:427-477 | CRYSTAL STRUCTURE OF NATIVE HEPARIN COFACTOR II |
1JMO | A:279-377,A:427-477 | CRYSTAL STRUCTURE OF THE HEPARIN COFACTOR II-S195A THROMBIN COMPLEX |
1JRR | A:208-309,A:385-411 | HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETIONMUTANT] COMPLEXED WITH PEPTIDE MIMICKING THE REACTIVE CENTER LOOP |
1JVQ | I:225-320,I:380-429; L:225-320,L:383-430 | CRYSTAL STRUCTURE AT 2.6A OF THE TERNARY COMPLEX BETWEEN ANTITHROMBIN, A P14-P8 REACTIVE LOOP PEPTIDE, AND AN EXOGENOUS TETRAPEPTIDE |
1KCT | A:195-289,A:344-394 | ALPHA1-ANTITRYPSIN |
1LJ5 | A:171-280,A:326-335,A:346-379 | 1.8A RESOLUTION STRUCTURE OF LATENT PLASMINOGEN ACTIVATOR INHIBITOR-1(PAI-1) |
1LK6 | I:225-320,I:380-429; L:225-320,L:383-430 | STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE |
1LQ8 | G:190-284,G:344-355; A:190-284,A:344-354; C:190-284,C:344-354; E:190-284,E:344-354 | CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR |
1NQ9 | L:225-320,L:383-427; I:225-320,I:383-428 | CRYSTAL STRUCTURE OF ANTITHROMBIN IN THE PENTASACCHARIDE-BOUND INTERMEDIATE STATE |
1OC0 | A:171-280,A:326-335,A:349-379 | PLASMINOGEN ACTIVATOR INHIBITOR-1 COMPLEX WITH SOMATOMEDIN B DOMAIN OF VITRONECTIN |
1OO8 | A:195-289,A:359-393 | CRYSTAL STRUCTURE OF A1PI-PITTSBURGH IN THE NATIVE CONFORMATION |
1OPH | A:195-289,A:359-394 | NON-COVALENT COMPLEX BETWEEN ALPHA-1-PI-PITTSBURGH AND S195A TRYPSIN |
1OYH | L:225-320,L:383-429; I:225-320,I:383-430 | CRYSTAL STRUCTURE OF P13 ALANINE VARIANT OF ANTITHROMBIN |
1PSI | A:195-289 | INTACT RECOMBINED ALPHA1-ANTITRYPSIN MUTANT PHE 51 TO LEU |
1QLP | A:195-289,A:344-394 | 2.0 ANGSTROM STRUCTURE OF INTACT ALPHA-1-ANTITRYPSIN: A CANONICAL TEMPLATE FOR ACTIVE SERPINS |
1QMN | A:194-288,A:348-395 | ALPHA1-ANTICHYMOTRYPSIN SERPIN IN THE DELTA CONFORMATION (PARTIAL LOOP INSERTION) |
1R1L | L:225-320,L:383-429; I:225-320,I:381-430 | STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE (FORMYL-NORLEUCINE-LF) |
1SR5 | A:225-320,A:385-428 | ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY COMPLEX STRUCTURE |
1T1F | A:225-320,A:380-429; B:225-320,B:380-429; C:225-320,C:380-429 | CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM |
1TB6 | I:225-320,I:386-429 | 2.5A CRYSTAL STRUCTURE OF THE ANTITHROMBIN-THROMBIN-HEPARIN TERNARY COMPLEX |
1WZ9 | A:170-275,A:328-375; B:170-275,B:328-375 | THE 2.1 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN |
1XQG | A:170-275,A:328-375; B:170-275,B:328-375 | 3.10 A CRYSTAL STRUCTURE OF MASPIN, SPACE GROUP P 4 21 2 |
1XQJ | A:170-275,A:328-375 | 3.10 A CRYSTAL STRUCTURE OF MASPIN, SPACE GROUP I 4 2 2 |
1XU8 | A:170-275,A:328-375; B:170-275,B:328-375 | THE 2.8 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN |
2ACH | A:194-288,A:348-358 | CRYSTAL STRUCTURE OF CLEAVED HUMAN ALPHA1-ANTICHYMOTRYPSIN AT 2.7 ANGSTROMS RESOLUTION AND ITS COMPARISON WITH OTHER SERPINS |
2ANT | L:225-320,L:378-429; I:225-320,I:383-430 | THE 2.6 A STRUCTURE OF ANTITHROMBIN INDICATES A CONFORMATIONAL CHANGE AT THE HEPARIN BINDING SITE |
2ARQ | A:208-309,A:382-411 | HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETION MUTANT] COMPLEXED WITH PEPTIDE N-ACETYL-TEAAAGDGGVMTGR-OH |
2ARR | A:208-309,A:382-411 | HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETION MUTANT] COMPLEXED WITH PEPTIDE N-ACETYL-TEAAAGMGGVMTGR-OH |
2B4X | L:225-320,L:383-430; I:225-320,I:381-431 | CRYSTAL STRUCTURE OF ANTITHROMBIN-III |
2B5T | I:225-320,I:380-429 | 2.1 ANGSTROM STRUCTURE OF A NONPRODUCTIVE COMPLEX BETWEEN ANTITHROMBIN, SYNTHETIC HEPARIN MIMETIC SR123781 AND TWO S195A THROMBIN MOLECULES |
2BEH | I:225-320,I:380-429; L:225-320,L:383-430 | CRYSTAL STRUCTURE OF ANTITHROMBIN VARIANT S137A/V317C/T401C WITH PLASMA LATENT ANTITHROMBIN |
2CEO | A:191-286,A:341-394; B:191-286,B:341-394 | THYROXINE-BINDING GLOBULIN COMPLEX WITH THYROXINE |
2D26 | A:195-289 | ACTIVE SITE DISTORTION IS SUFFICIENT FOR PROTEINASE INHIBIT SECOND CRYSTAL STRUCTURE OF COVALENT SERPIN-PROTEINASE COMPLEX |
2GD4 | C:225-320,C:383-430; I:225-320,I:383-430 | CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX |
2HI9 | A:190-284,A:344-387; C:189-285,C:339-387; B:190-284,B:344-387 | CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR |
2HIJ | L:225-320,L:383-430; I:225-320,I:383-430 | CRYSTAL STRUCTURE OF P14 ALANINE VARIANT OF ANTITHROMBIN |
2OL2 | B:190-284,B:360-387; A:190-284,A:344-387 | HIGH RESOLUTION STRUCTURE OF NATIVE PCI IN SPACE GROUP P21 |
2QUG | A:195-289,A:344-392 | CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN, CRYSTAL FORM A |
2RIV | A:191-286 | CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN |
2RIW | A:191-286 | THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN COMPLEXED WITH THYROXINE |
2VDX | A:185-279,A:339-382; B:185-279,B:339-382 | CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN |
2VDY | A:185-279,A:339-382; B:185-279,B:339-382 | CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN COMPLEXED WITH CORTISOL |
3B9F | I:190-284,I:344-387 | 1.6 A STRUCTURE OF THE PCI-THROMBIN-HEPARIN COMPLEX |
3CAA | A:194-288,A:348-358 | CLEAVED ANTICHYMOTRYPSIN A347R |
3CVM | A:171-280,A:326-335,A:339-379; B:171-280,B:326-335,B:339-379 | HIGH RESOLUTION STRUCTURE OF A STABLE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN ITS PROTEASE CLEAVED FORM |
3CWL | A:195-289,A:344-394 | CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN, CRYSTAL FORM B |
3CWM | A:195-289,A:344-393 | CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN COMPLEXED WITH CITRATE |
3DLW | A:194-290,A:350-397 | ANTICHYMOTRYPSIN |
3DRM | A:195-289,A:352-393 | 2.2 ANGSTROM CRYSTAL STRUCTURE OF THR114PHE ALPHA1-ANTITRYPSIN |
3DRU | C:195-289,C:344-393; B:195-289,B:344-393; A:195-289,A:344-394 | CRYSTAL STRUCTURE OF GLY117PHE ALPHA1-ANTITRYPSIN |
3DY0 | A:190-284,A:344-353 | CRYSTAL STRUCTURE OF CLEAVED PCI BOUND TO HEPARIN |
3EOX | A:171-280,A:326-342 | HIGH QUALITY STRUCTURE OF CLEAVED PAI-1-STAB |
3F02 | B:193-294; A:193-294 | CLEAVED HUMAN NEUROSERPIN |
3F1S | A:221-318,A:372-423 | CRYSTAL STRUCTURE OF PROTEIN Z COMPLEXED WITH PROTEIN Z-DEPENDENT INHIBITOR |
4CAA | A:194-288,A:348-358 | CLEAVED ANTICHYMOTRYPSIN T345R |
7API | A:195-289 | THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM |
8API | A:195-289 | THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM |
9PAI | A:189-298,A:344-353 | CLEAVED SUBSTRATE VARIANT OF PLASMINOGEN ACTIVATOR INHIBITOR-1 |